HIV Entry in Macrophages is Dependent on Intact Lipid Rafts

Overview

Journal Virology

Specialty Microbiology

Date 2009 Feb 3

PMID 19185899

Citations 69

Authors

Gemma C Carter

Laura Bernstone

Dhaval Sangani

Jessica Wynter Bee

Thomas Harder

William James

Affiliations

Soon will be listed here.

Abstract

Macrophages are an important natural target cell for HIV-1, but previous studies of virus entry into these cells are limited, and the involvement of membrane cholesterol and lipid rafts is unknown. Cholesterol disruption of macrophage membranes using four pharmacological agents acting by different mechanisms: methyl-beta cyclodextrin, nystatin, filipin complex and Lovastatin, all significantly inhibited productive HIV entry and reverse transcription. The inhibitory effects of these drugs resulted in decreased virus release from infected cells, and could be substantially reversed by the addition of water-soluble cholesterol. The virus bound equally to cholesterol-disrupted cells even though HIV receptor expression levels were significantly reduced. Macrophage CD4 and CCR5 were found to partition with the detergent-resistant membranes with a typical raft-associating protein flotillin-1. HIV particles were observed co-localising with a marker of lipid rafts (CTB-FITC) early post infection. These data suggest that macrophage membrane cholesterol is essential for HIV entry, and implicate lipid raft involvement.

Citing Articles

The translational landscape of HIV-1 infected cells reveals key gene regulatory principles.

Kibe A, Buck S, Gribling-Burrer A, Gilmer O, Bohn P, Koch T Nat Struct Mol Biol. 2025; .

PMID: 39815046 DOI: 10.1038/s41594-024-01468-3.

Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future.

Fantini J, Chahinian H, Yahi N Int J Mol Sci. 2023; 24(3).

PMID: 36768244 PMC: 9915253. DOI: 10.3390/ijms24031923.

Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry.

Singh P, Kumar V, Lee G, Jung T, Ha M, Hong J Int J Mol Sci. 2022; 23(24).

PMID: 36555761 PMC: 9784205. DOI: 10.3390/ijms232416122.

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells.

Bakillah A, Al Hejji F, Almasaud A, Al Jami H, Hawwari A, Al Qarni A Nutrients. 2022; 14(16).

PMID: 36014919 PMC: 9415163. DOI: 10.3390/nu14163417.

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.

Mokhtary P, Pourhashem Z, Mehrizi A, Sala C, Rappuoli R Biomedicines. 2022; 10(8).

PMID: 36009408 PMC: 9405509. DOI: 10.3390/biomedicines10081861.

References

Funk A, Mhamdi M, Hohenberg H, Heeren J, Reimer R, Lambert C . Duck hepatitis B virus requires cholesterol for endosomal escape during virus entry. J Virol. 2008; 82(21):10532-42. PMC: 2573206. DOI: 10.1128/JVI.00422-08. View

Giguere J, Tremblay M . Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J Virol. 2004; 78(21):12062-5. PMC: 523291. DOI: 10.1128/JVI.78.21.12062-12065.2004. View

Castrillo A, Joseph S, Vaidya S, Haberland M, Fogelman A, Cheng G . Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell. 2003; 12(4):805-16. DOI: 10.1016/s1097-2765(03)00384-8. View

Campbell S, Crowe S, Mak J . Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS. 2002; 16(17):2253-61. DOI: 10.1097/00002030-200211220-00004. View

Manes S, del Real G, Lacalle R, Lucas P, Sanchez-Palomino S, Delgado R . Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 2001; 1(2):190-6. PMC: 1084257. DOI: 10.1093/embo-reports/kvd025. View

Anderson H, Chen Y, Norkin L . Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell. 1996; 7(11):1825-34. PMC: 276029. DOI: 10.1091/mbc.7.11.1825. View

Bukrinsky M, Sviridov D . Human immunodeficiency virus infection and macrophage cholesterol metabolism. J Leukoc Biol. 2006; 80(5):1044-51. DOI: 10.1189/jlb.0206113. View

Risselada H, Marrink S . The molecular face of lipid rafts in model membranes. Proc Natl Acad Sci U S A. 2008; 105(45):17367-72. PMC: 2579886. DOI: 10.1073/pnas.0807527105. View

van t Wout A, Swain J, Schindler M, Rao U, Pathmajeyan M, Mullins J . Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol. 2005; 79(15):10053-8. PMC: 1181597. DOI: 10.1128/JVI.79.15.10053-10058.2005. View

10.

Mujawar Z, Rose H, Morrow M, Pushkarsky T, Dubrovsky L, Mukhamedova N . Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006; 4(11):e365. PMC: 1629034. DOI: 10.1371/journal.pbio.0040365. View

11.

Steffens C, Hope T . Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol. 2004; 78(17):9573-8. PMC: 506925. DOI: 10.1128/JVI.78.17.9573-9578.2004. View

12.

Nabatov A, Pollakis G, Linnemann T, Paxton W, de Baar M . Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1. PLoS One. 2007; 2(5):e470. PMC: 1867858. DOI: 10.1371/journal.pone.0000470. View

13.

Del Real G, Jimenez-Baranda S, Lacalle R, Mira E, Lucas P, Gomez-Mouton C . Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J Exp Med. 2002; 196(3):293-301. PMC: 2193941. DOI: 10.1084/jem.20020308. View

14.

Del Real G, Jimenez-Baranda S, Mira E, Lacalle R, Lucas P, Gomez-Mouton C . Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med. 2004; 200(4):541-7. PMC: 2211926. DOI: 10.1084/jem.20040061. View

15.

Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier J . HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem. 2002; 278(5):3153-61. DOI: 10.1074/jbc.M207371200. View

16.

Sun X, Whittaker G . Role for influenza virus envelope cholesterol in virus entry and infection. J Virol. 2003; 77(23):12543-51. PMC: 262566. DOI: 10.1128/jvi.77.23.12543-12551.2003. View

17.

Gartner S, Markovits P, Markovitz D, Betts R, Popovic M . Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA. 1986; 256(17):2365-71. View

18.

Bender F, Whitbeck J, Ponce de Leon M, Lou H, Eisenberg R, Cohen G . Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol. 2003; 77(17):9542-52. PMC: 187402. DOI: 10.1128/jvi.77.17.9542-9552.2003. View

19.

Viard M, Parolini I, Sargiacomo M, Fecchi K, Ramoni C, Ablan S . Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol. 2002; 76(22):11584-95. PMC: 136803. DOI: 10.1128/jvi.76.22.11584-11595.2002. View

20.

Harder T, Kuhn M . Selective accumulation of raft-associated membrane protein LAT in T cell receptor signaling assemblies. J Cell Biol. 2000; 151(2):199-208. PMC: 2192654. DOI: 10.1083/jcb.151.2.199. View